High D-dimer plasma concentration in systemic sclerosis patients: Prevalence and association with vascular

Sofia Furtado1,2, Bertrand Dunogué1, Georges Jourdi3,4

  • 1Service de Médecine Interne, Centre de référence des maladies auto-immunes systémiques rares d'Ile-de-France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Descartes, Paris, France.

Insights

Elevated D-dimer levels are common in systemic sclerosis patients. These high levels correlate with increased microvascular and macrovascular complications, suggesting D-dimer as a potential risk indicator.

Area of Science:

  • Rheumatology
  • Hematology
  • Vascular Medicine

Background:

  • Systemic sclerosis (SSc) is a complex autoimmune disease characterized by microvascular and macrovascular complications.
  • D-dimer, a marker of coagulation and fibrinolysis, has not been extensively studied in the context of SSc complications.

Purpose of the Study:

  • To determine the frequency of elevated D-dimer plasma concentration in patients with systemic sclerosis.
  • To evaluate the association between elevated D-dimer and SSc-specific microvascular and macrovascular complications.

Main Methods:

  • Retrospective observational study.
  • Analysis of D-dimer levels and clinical data from 214 SSc patients followed between 2010 and 2018.
  • Evaluation of microvascular (digital ulcers, renal crisis, pulmonary arterial hypertension) and macrovascular complications.

Main Results:

  • Elevated D-dimer was observed in 43.5% of SSc patients.
  • Microvascular complications were more frequent in patients with elevated D-dimer, especially after excluding cancer/VTE history (60.5% vs 44.8%, p=0.04).
  • Macrovascular complications were significantly associated with high D-dimer levels (11.8% vs 3.3%, p=0.03), and new events occurred only in this group.

Conclusions:

  • High D-dimer levels are frequent in systemic sclerosis.
  • Elevated D-dimer is associated with both microvascular and macrovascular complications in SSc patients, even after adjusting for confounders.
  • D-dimer may serve as a valuable biomarker for predicting complications in systemic sclerosis.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
50
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
44
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
94
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
952
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
38
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
52